Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

November 26, 2020: Event biotech agora / Adocia Presentation from adocia (English version will be available soon)

Latest Press Releases

2020/11/06Number of shares and voting rights of ADOCIA as of October 31, 2020
2020/10/20Adocia Announces Third Quarter 2020 Financial Results

All Press releases

Next events

January 13-16, 2021 38th Annual J.P. Morgan Healthcare Conference. Virtual Event

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

November 14: Delphine Arduini, who has been living with type 1 diabetes since she was 16 years old, shares her experience, treatment revolutions and her hopes in a video on the occasion of World Diabetes Day.

Thursday, November 26 at 6:00 pm: Participate in the video-conference Adocia hosted by Biotech Agora (French only)